The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective observational study for treatment resistance-related gene screening using plasma circulating tumor DNA in the third generation EGFR TKI osimertinib therapy elucidator.
 
Akihiro Tamiya
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Kissei Pharmaceutical; Lilly Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Shun-Ichi Isa
No Relationships to Disclose
 
Yoshihiko Taniguchi
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; MSD; Mundipharma; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Ono Pharmaceutical
 
Masahiko Ando
Consulting or Advisory Role - Asahi Kasei
Research Funding - Kyowa Hakko Kirin (Inst)
 
Shinji Atagi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Hisamitsu Pharmaceutical; Lilly Japan; MSD K.K; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Lilly Japan (Inst); MSD K.K (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Yasuhiro Koh
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Hitachi; Kyowa Hakko Kirin; Novartis; Pfizer; Thermo Fisher Scientific; Tosoh Corporation
Consulting or Advisory Role - Tosoh Corporation
Research Funding - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Novartis; On-chip Biotechnologies; TERUMO; Toppan Printing Co.